Boomerang Medical is a women-led bioelectronic medicine company on a mission to disrupt the treatment of autoimmune diseases. The company is developing a bioelectric neuromodulation technology, which has been granted Breakthrough Device Designation by the FDA for the treatment of Crohn's disease and ulcerative colitis. The technology is currently being evaluated in an FDA-approved clinical trial at leading IBD centers in the US.
Inflammatory Bowel Disease (IBD) is one of the most debilitating autoimmune diseases, affecting millions globally. Living with Crohn's disease or ulcerative colitis impacts not just physical health, but also work, relationships, and well-being. Current treatments include medications and surgery, but the complexity of the condition means that there is always room for innovative approaches.
What if the next big leap in managing IBD is already hardwired into our bodies? That's the question propelling our focus on neuromodulation, a promising frontier in bioelectronic medicine.
Boomerang Medical is headquartered in the heart of Silicon Valley on the campus of El Camino Hospital in Mountain View, California. We are proud to be a Company–In-Residence at the prestigious Fogarty Innovation incubator–the only healthcare-focused incubator of its kind in the US–giving us access to the brightest minds and expertise in the medical technology industry.
Meet the Team
Board of Directors + Advisors
Boomerang Medical is proud to be a portfolio company of
Company-In-Residence at Fogarty Innovation.
President & CEO
Chief Executive Officer
Tom Shehab, MD
Chief Financial Officer
Hatteras Venture Partners
Director of Innovation Acceleration